Key California Lawmaker Calls Eli Lilly’s Behavior ‘Disingenuous And Offensive’
(By Barbara Feder Ostrov for California Healthline produced by Kaiser Health News) Seven months after a controversial California law took effect
Read More
Part D/Prescription Drugs
Do American patients have better access to cancer drugs?
Do U.S. patients have better access to cancer drugs? When comparing the U.S. and the European Union, the question isn’t
Read MoreTrump Administration Sinks Teeth Into Paring Down Drug Prices, On 5 Key Points
(By Sarah Jane Tribble for Kaiser Health News) Three months after President Donald Trump announced his blueprint to bring down
Read MoreStates Question Costs Of Middlemen That Manage Medicaid Drug Benefits
(By Alison Kodjak for NPR) Several states are questioning the cost of using pharmacy middlemen to manage their prescription drug
Read MorePharmacy-Made Pain Creams Flagged On Fears Of Medicare Fraud And Risk
(By Julie Appleby for Kaiser Health News) Medicare pays hundreds of millions of dollars each year for prescription creams, gels
Read MoreInsurers, PMBs will be able to negotiate prices for drugs paid by Medicare Part B
The Health and Human Services Secretary Alex Azar said, starting next year Medicare Advantage plans will get new powers to
Read MoreHumana sues drug manufacturers, alleges price-fixing
(By Julie Spitzer for Becker’s Hospital Review) Humana filed a lawsuit Aug. 3 against nearly 30 pharmaceutical companies, alleging they united to
Read MoreCan a phone app’s warnings to avoid risky friends and places prevent opioid addiction relapses?
(By Orly Nadell Farber for STAT) You’re in recovery from opioid addiction, and your walk to work takes you down
Read MoreFDA will broaden how it evaluates new addiction treatment drugs
(By Lev Facher for STAT) The Food and Drug Administration on Monday announced a shift in the way it evaluates drugs
Read MorePoison control calls spike for unapproved drug that produces opioid-like highs
(By Megan Thielking for STAT) Calls to U.S. poison control centers about an unapproved antidepressant that has opioid-like effects have
Read More